These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 23014898

  • 1. Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
    Valero García S, López Briz E, Escobar Cava P, Balaguer J, Pelufo A, Megías JE, Poveda Andrés JL.
    J Oncol Pharm Pract; 2013 Jun; 19(2):159-64. PubMed ID: 23014898
    [Abstract] [Full Text] [Related]

  • 2. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP.
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
    Vajzovic LM, Murray TG, Aziz-Sultan MA, Schefler AC, Fernandes CE, Wolfe SC, Hess DJ, Dubovy SR.
    Arch Ophthalmol; 2010 Dec; 128(12):1619-23. PubMed ID: 21149791
    [No Abstract] [Full Text] [Related]

  • 4. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA.
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
    Muen WJ, Kingston JE, Robertson F, Brew S, Sagoo MS, Reddy MA.
    Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion of melphalan.
    Hadjistilianou T, Coriolani G, Bracco S, Gennari P, Caini M, Cerase A, Galimberti D, De Francesco S, De Luca M, Mastrangelo D.
    J Pediatr Ophthalmol Strabismus; 2014 Mar; 51(1):32-8. PubMed ID: 24308859
    [Abstract] [Full Text] [Related]

  • 7. Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma.
    Phillips TJ, McGuirk SP, Chahal HK, Kingston J, Robertson F, Brew S, Roebuck D, Hungerford JL, Herod J.
    Paediatr Anaesth; 2013 Oct; 23(10):940-5. PubMed ID: 23668238
    [Abstract] [Full Text] [Related]

  • 8. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 9. Alternative treatment for retinoblastoma: Intra-arterial chemotherapy with melphalan.
    De Freytas A, Harto-Castaño M, Barranco H, Aviño J, Martinez-Costa R.
    Arch Soc Esp Oftalmol; 2015 Oct; 90(10):487-90. PubMed ID: 26008929
    [Abstract] [Full Text] [Related]

  • 10. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
    Suzuki S, Yamane T, Mohri M, Kaneko A.
    Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
    [Abstract] [Full Text] [Related]

  • 11. [Analysis on the safety of ophthalmic artery cannulation for intra-arterial chemotherapy in 42 patients with intraocular stage retinoblastoma].
    Liu QL, Wang YF, Mao GS, Yang XJ, Sun YF, Miao LX, Wang J, Yuan HL, Li YS, Liu HY, Wang XL, Zhao F.
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):793-7. PubMed ID: 23302573
    [Abstract] [Full Text] [Related]

  • 12. Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium.
    Materin MA, Kuzmik GA, Jubinsky PT, Minja FJ, Asnes JD, Bulsara KR.
    J Neurointerv Surg; 2013 Nov; 5(6):e42. PubMed ID: 23188789
    [Abstract] [Full Text] [Related]

  • 13. Complete regression of retinoblastoma following intra-arterial chemotherapy.
    Ni N, Shields CL, Bianciotto CG, Jabbour PM, Rosenwasser RH, Shields JA.
    J Pediatr Ophthalmol Strabismus; 2011 Jun 07; 48 Online():e23-5. PubMed ID: 21634361
    [Abstract] [Full Text] [Related]

  • 14. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.
    Venturi C, Bracco S, Cerase A, Cioni S, Galluzzi P, Gennari P, Vallone IM, Tinturini R, Vittori C, De Francesco S, Caini M, D'Ambrosio A, Toti P, Renieri A, Hadjistilianou T.
    Acta Ophthalmol; 2013 Jun 07; 91(4):335-42. PubMed ID: 22268993
    [Abstract] [Full Text] [Related]

  • 15. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.
    Yamane T, Kaneko A, Mohri M.
    Int J Clin Oncol; 2004 Apr 07; 9(2):69-73. PubMed ID: 15108036
    [Abstract] [Full Text] [Related]

  • 16. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
    Akyüz C, Kıratlı H, Şen H, Aydın B, Tarlan B, Varan A.
    Ophthalmologica; 2015 Apr 07; 234(4):227-32. PubMed ID: 26368674
    [Abstract] [Full Text] [Related]

  • 17. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
    Padrón-Pérez N, Català-Mora J.
    J Fr Ophtalmol; 2014 Feb 07; 37(2):176. PubMed ID: 24210940
    [No Abstract] [Full Text] [Related]

  • 18. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
    Solana-Altabella A, Valero S, Balaguer J, Escobar-Cava P, Barranco H, López E, Ribes-Artero H, Poveda JL.
    J Oncol Pharm Pract; 2020 Dec 07; 26(8):1829-1835. PubMed ID: 32063104
    [Abstract] [Full Text] [Related]

  • 19. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.
    Hutchinson A, Kaliki S, Shields CL.
    J Pediatr Ophthalmol Strabismus; 2012 Mar 27; 49 Online():e15-8. PubMed ID: 22443587
    [Abstract] [Full Text] [Related]

  • 20. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
    Rojanaporn D, Kaliki S, Bianciotto CG, Iturralde JC, Say EA, Shields CL.
    Arch Ophthalmol; 2012 May 27; 130(5):585-90. PubMed ID: 22652844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.